Fulgent Genetics, Inc. 8-K

What Happened

• Fulgent Genetics, Inc. (FLGT) filed an 8-K reporting that at its May 14, 2026 Annual Meeting shareholders approved the Fulgent Genetics, Inc. 2026 Equity Incentive Plan (the “2026 Plan”), which replaces the company’s Prior Plan. The 2026 Plan authorizes issuance of 2,000,000 new common shares plus up to 1,500,000 additional shares if awards under the Prior Plan are forfeited or cancelled on or after the Effective Date. No new grants will be made under the Prior Plan after May 14, 2026; outstanding Prior Plan awards remain in effect per their terms.
• The meeting had a quorum of 24,578,996 shares present (≈83% of outstanding eligible shares). Shareholders also elected directors (Ming Hsieh, Linda Dong, Michael Nohaile, Ph.D., and Regina Groves), ratified Deloitte & Touche LLP as auditor, and approved the company’s executive compensation on a non‑binding advisory basis.

Key Details

• 2026 Plan authorized: 2,000,000 new shares; up to 1,500,000 additional shares contingent on forfeitures/cancellations of Prior Plan awards.
• Vote totals (selected): 2026 Plan — For 18,693,758; Against 3,513,983; Broker non-vote 2,323,053. Advisory Say-on-Pay — For 19,800,226; Against 2,410,239.
• Director election votes (For / Withheld): Ming Hsieh 21,979,668 / 276,275; Linda Dong 16,836,781 / 5,419,162; Michael Nohaile 17,258,629 / 4,997,314; Regina Groves 16,240,666 / 6,015,277.
• Auditor ratification: Deloitte & Touche LLP ratified (For 24,470,414; Against 87,192).

Why It Matters

• Equity compensation: The 2026 Plan sets the framework for future stock-based awards (options, RSUs, etc.), which management can use to attract and retain employees and align incentives with shareholders. The authorized share amounts indicate potential dilution that investors should monitor as awards are granted.
• Governance signals: Re-election of directors and ratification of the auditor maintain board and audit continuity. The strong, non-binding shareholder support for executive compensation (Say-on-Pay) suggests general investor approval of the company’s pay practices.
• Where to find more: The full 2026 Plan text was filed as an exhibit to the 8-K for those wanting the detailed terms and award mechanics.